Evidence map›Paper›PMID 28664086›Full record

ReviewIntegrative medicine research2014

Current knowledge on alleviating

Malliga Raman Murali, Sangeetha Vasudevaraj Naveen, Chang Gue Son, Hanumantha Rao Balaji Raghavendran

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Integrative medicine research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Zuo Jin Wan Reverses DDP Resistance in Gastric Cancer through ROCK/PTEN/PI3K Signaling Pathway.Evidence-based complementary and alternative medicine : eCAM · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Malliga Raman MuraliTissue Engineering Group, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Department of Orthopaedic surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Sangeetha Vasudevaraj NaveenTissue Engineering Group, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Department of Orthopaedic surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Chang Gue SonLiver and Immunology Research Center, Oriental Medical College of Daejeon University, Daejeon, South Korea.
Hanumantha Rao Balaji RaghavendranTissue Engineering Group, National Orthopaedic Centre of Excellence for Research and Learning (NOCERAL), Department of Orthopaedic surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
University of Malaya · MYDaejeon Oriental Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trialcomplimentary medicineGram-negative bacteriumHelicobacter pylorinatural products

Identifiers

PMID28664086
PMCPMC5481734
OpenAlexW2116374777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.